(Q44602591)

4 December 2017

Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection (English)

1 reference

4 December 2017

1 reference

1 reference

M Puoti

1

1 reference

4 December 2017

S Rossi

2

1 reference

4 December 2017

M A Forleo

3

1 reference

4 December 2017

S Zaltron

4

1 reference

4 December 2017

A Spinetti

5

1 reference

4 December 2017

V Putzolu

6

1 reference

4 December 2017

A Rodella

7

1 reference

4 December 2017

G Carosi

8

1 reference

4 December 2017

1 July 1998

1 reference

4 December 2017

Journal of Hepatology

1 reference

4 December 2017

29

1 reference

4 December 2017

1

1 reference

4 December 2017

45-52

1 reference

Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS.

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Hepatitis delta virus infection of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Therapy of chronic delta hepatitis with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Use of α-interferon in the treatment of chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Evaluation of hepatitis delta virus RNA levels during interferon therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Patterns of hepatitis delta virus reinfection and disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980177-3

7 January 2021

10.1016/S0168-8278(98)80177-3

Identifiers

DOI

1 reference

4 December 2017

1 reference